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The optimal method for early detection of breast cancer in
premenopausal women is not known. To date, mammo-
graphic screening and physical exam are the best available
approaches for early detection in the general population.
However, these methods may not be sufficient in young
women. Therefore, there is an urgent need for new
approaches that can augment mammographic screening
and physical exam, particularly for women at high risk for
developing breast cancer, such as carriers of BRCA1/2
mutations, who are known to face markedly elevated life-
time risks for cancer. Therefore, women at high risk constitute
the population that will benefit most from new breast screening
technologies and early detection strategies.
Mammary epithelial cells destined to progress to cancer
may have accumulated a number of premalignant genetic
changes, prior to the onset of cancer. Therefore, it may be
possible to improve upon cytologic assessment of these
cells by simultaneously screening for genomic aberra-
tions. This provides a realistic opportunity to improve the
detection of premalignant breast changes prior to the
onset of cancer. There have been several reports showing
the feasibility of studying individual, or a combination of
two biomarkers, to assess the ductal fluid. However, no
studies have been performed where a panel of multiple biomar-
kers were evaluated simultaneously, using the same fluid sam-
ple.  This is particularly significant since it is not clear
which biomarker(s) will be most useful for early detection
of breast cancer, making a panel of markers more desira-
ble than an individual one. We believe that we can signif-
icantly improve the diagnostic value of ductal fluid by
maximizing the information one can derive from each
specimen.
from 6th International Symposium on the Intraductal Approach to Breast Cancer
Santa Monica, CA, USA. 19–21 February 2009
Published: 24 July 2009
BMC Proceedings 2009, 3(Suppl 5):S21 doi:10.1186/1753-6561-3-S5-S21
<supplement> <title> <p>6th International Symposium on the Intraductal Approach to Breast Cancer</p> </title> <editor>Susan Rochman, Dixie Mills, Julian Kim, Henry Kuerer and Susan Love</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1753-6561-3-S5-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1753-6561-3-S5-info.pdf</url> </supplement>
This abstract is available from: http://www.biomedcentral.com/1753-6561/3/S5/S21
© 2009 Haddad; licensee BioMed Central Ltd. 